United States · Series B startup

Who invested in Aera Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$193Mraised across 1 round since 2023, from 1 source

Latest round
Series B, $193MFeb 2023
Investors
3
See who backed them

The rounds

  1. Feb 2023

Founders and team

From Aera Therapeutics's own website: 3 on the team.

  • Stephanie SousaChief Operating Officer
  • Brittany HasiliDirector, Finance & Accounting
  • Kyle CrossDirector, IT, Lab Operations & Facilities

Everyone who backed them

Google VenturesCorporate VC1round
Lux CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aera Therapeutics

Who invested in Aera Therapeutics?

Aera Therapeutics's investors include Google Ventures, Lux Capital and ARCH Venture Partners.

How much has Aera Therapeutics raised?

Aera Therapeutics has raised $193M across 1 round since 2023.

When did Aera Therapeutics last raise?

Aera Therapeutics's most recent round was a Series B of $193M in Feb 2023.

What was Aera Therapeutics's biggest round?

Its most recent round, $193M in Feb 2023, is also its largest on record.

Who backed Aera Therapeutics first?

Aera Therapeutics's first round on record, in Feb 2023, was backed by Google Ventures, Lux Capital and ARCH Venture Partners.

What stage is Aera Therapeutics at?

Aera Therapeutics's latest named round is a Series B, in Feb 2023.

Where is Aera Therapeutics based?

Aera Therapeutics is based in the United States.

Companies like Aera Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.